• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

New Opportunities

Quote




Is Sage only hiring for Psych positions now and not PCP/OBGYN? I don’t see those positions listed on the website anymore. I had a phone screen with recruiter late April for a PCP/OBGYN.
 




I had phone screens with both companies. Biogen recruiter said there is no way anyone is starting at 185k as that is a salary that can be worked towards. Sage is offering $165k for the max salary.
 












anonymous said:
Remember some will be hired as low as 125. Nothing is guaranteed and all depends on your exp level as well as how badly a hiring mgr wants somebody.
Click to expand...

Agreed everyone thinks the norm pay range is based on their own personal situation. There is a good 50k sliding scale in the pay range here. Reps get pissed but it’s the reality.
 












anonymous said:
From very good inside sources, the plan is to charge an insane amount for this drug. Numerous step-edits expected as best case scenario. No one will be covering and Sr Leadership not willing to discount for access. This is going to be another Sage nightmare! Charm you with the "culture" and allow you to fail in the field. Get prepared for heavy metrics (just look at leadership and their background). You can call this "specialty" to gain interest from good candidates however this will be highly a primary care type position for those in the field. Not enough psychiatry to drive demand they expect with the bait and switch coming to focus on where patients are being seen by providers (Primary Care). Good luck if you are in a difficult access area as metrics and performance wont be an excuse or consideration for goal setting.
Unrealistic expectations for an average clinical effect at a premium price with no access = Dead On Arrival. This will be another Zulresso experience for those that lived it, only with more greed and leadership that is lacking.
Shit flows downhill and there is a huge pile at the top ready to come down. Be very aware if interviewing and ask the right questions. They will bribe you with stock options and the stock hasnt moved in preparation for this drug. It is filled with doubt in the medical community due to more negatively around it than positivity. Just look at market reaction to any Sage news: always goes down!
How do I know? Have several connections with Sage, talked to clinicians about their lack of desire for this drug (which I have great connections due to many years calling on psychiatry). Finally, I passed on a decent offer to lead a regional team knowing bonus are going to be few and far between (maybe AZ, TX & FL have a chance). This is not the greener grass! My advice based off of internal Sage & high-profile psych conversations with those in the "know". You can take or ignore what I am writing, but facts are facts.
Click to expand...


This!
 




anonymous said:
From very good inside sources, the plan is to charge an insane amount for this drug. Numerous step-edits expected as best case scenario. No one will be covering and Sr Leadership not willing to discount for access. This is going to be another Sage nightmare! Charm you with the "culture" and allow you to fail in the field. Get prepared for heavy metrics (just look at leadership and their background). You can call this "specialty" to gain interest from good candidates however this will be highly a primary care type position for those in the field. Not enough psychiatry to drive demand they expect with the bait and switch coming to focus on where patients are being seen by providers (Primary Care). Good luck if you are in a difficult access area as metrics and performance wont be an excuse or consideration for goal setting.
Unrealistic expectations for an average clinical effect at a premium price with no access = Dead On Arrival. This will be another Zulresso experience for those that lived it, only with more greed and leadership that is lacking.
Shit flows downhill and there is a huge pile at the top ready to come down. Be very aware if interviewing and ask the right questions. They will bribe you with stock options and the stock hasnt moved in preparation for this drug. It is filled with doubt in the medical community due to more negatively around it than positivity. Just look at market reaction to any Sage news: always goes down!
How do I know? Have several connections with Sage, talked to clinicians about their lack of desire for this drug (which I have great connections due to many years calling on psychiatry). Finally, I passed on a decent offer to lead a regional team knowing bonus are going to be few and far between (maybe AZ, TX & FL have a chance). This is not the greener grass! My advice based off of internal Sage & high-profile psych conversations with those in the "know". You can take or ignore what I am writing, but facts are facts.
Click to expand...

interesting
 




















anonymous said:
sounds like you never got over what happened to you in round 1
Click to expand...

not at all. Moved on to an organization that has its act together and making bank. And am treated very well. No we don’t have booze in the fridge at home office but we have proven that we can launch a blockbuster, help patients and treat people well. Best of luck.
 




anonymous said:
not at all. Moved on to an organization that has its act together and making bank. And am treated very well. No we don’t have booze in the fridge at home office but we have proven that we can launch a blockbuster, help patients and treat people well. Best of luck.
Click to expand...
sounds like you never got over what happened to you in round 1
 








anonymous said:
I had an initial phone screen with Sage but haven’t heard anything yet. I did look up leadership on Linked In and you are absolutely right. Given their lack of experience, I’m not sure I would want to work at Sage. The lack of experience seems as if they are in over their heads. Is that a correct assessment?
Click to expand...


Sagian here. You nailed it. But they get props for diversity and inclusion because that counts more these days than competence.
 








anonymous said:
Sagian here. You nailed it. But they get props for diversity and inclusion because that counts more these days than competence.
Click to expand...
Translation: I’m Caucasian so my success should be handed to me. If a diverse candidate was hired it’s only because of a D&I initiative. Shut the fuck up, lunch deliverer.
 




Top Bottom
Back
Quote